ReviewCancers2021

Venetoclax in Acute Myeloid Leukemia: Molecular Basis, Evidences for Preclinical and Clinical Efficacy and Strategies to Target Resistance.

Sylvain Garciaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.